Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of omega-3 fatty acids on the perioperative immune response and erythrocyte function
2013-003664-32Phase 2Active
- Sponsor
- Noordwest Ziekenhuisgroep
- Start
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of eicosapentaenoic acid + docosahexaenoic acid in colon cancer and Immune disorder (2 arms), sponsored by Noordwest Ziekenhuisgroep. Primary endpoint: Ex vivo IL-6 production in LPS-stimulated whole blood cells. Started Nov 2013; status: active.
02
Drugs
eicosapentaenoic acid + docosahexaenoic acid
03
Conditions
colon cancerImmune disorder
Beyond the preview
Go deeper on 2013-003664-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003664-32.